Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Triumph Capital Management increased its Pfizer stake by 20%, holding over 10,000 shares worth $273,000. Several other firms ...

JPMorgan heeft dinsdag zijn neutrale beoordeling voor het aandeel Pfizer (NYSE:PFE) herbevestigd met een ongewijzigd koersdoel van $ 30,00. De evaluatie volgde op het eerstekvartaalrapport van Pfizer, ...

BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer Inc. (NYSE:PFE) and kept the price target the same at ...

How many shares of Pfizer should you own to make $10,000 in annual dividend income? Where to invest $1,000 right now? Our ...

Pfizer will pay China’s 3SBio $1.25 billion up front to access a cancer drug that could rival Akeso and Summit’s closely ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

Analyst targets range from $22 to $42 per share, with significant developments expected in oncology, vaccines, and cardiometabolic research. Access the comprehensive Pro Research Report for Pfizer and ...